| Product Code: ETC10499022 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India pharmaceutical market import shipment demonstrated a steady growth trend with a CAGR of 4.3% from 2020 to 2024. In the latest period, between 2023 and 2024, the growth rate accelerated to 5.6%, indicating increasing momentum. Overall, the market expansion remained consistent and robust over the specified timeframe.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India AI in Pharmaceutical Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India AI in Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 India AI in Pharmaceutical Market - Industry Life Cycle |
3.4 India AI in Pharmaceutical Market - Porter's Five Forces |
3.5 India AI in Pharmaceutical Market Revenues & Volume Share, By Market Type, 2021 & 2031F |
3.6 India AI in Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 India AI in Pharmaceutical Market Revenues & Volume Share, By AI Technology, 2021 & 2031F |
3.8 India AI in Pharmaceutical Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India AI in Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare solutions in India |
4.2.2 Growing adoption of artificial intelligence (AI) technology in drug discovery and development processes |
4.2.3 Government initiatives and investments to promote AI innovation in the pharmaceutical sector |
4.3 Market Restraints |
4.3.1 Data privacy and security concerns related to the use of AI in handling sensitive patient information |
4.3.2 Lack of regulatory clarity and guidelines for the integration of AI in pharmaceutical practices in India |
5 India AI in Pharmaceutical Market Trends |
6 India AI in Pharmaceutical Market, By Types |
6.1 India AI in Pharmaceutical Market, By Market Type |
6.1.1 Overview and Analysis |
6.1.2 India AI in Pharmaceutical Market Revenues & Volume, By Market Type, 2021 - 2031F |
6.1.3 India AI in Pharmaceutical Market Revenues & Volume, By Drug Discovery, 2021 - 2031F |
6.1.4 India AI in Pharmaceutical Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.1.5 India AI in Pharmaceutical Market Revenues & Volume, By Manufacturing, 2021 - 2031F |
6.1.6 India AI in Pharmaceutical Market Revenues & Volume, By Marketing, 2021 - 2031F |
6.1.7 India AI in Pharmaceutical Market Revenues & Volume, By Sales & Distribution, 2021 - 2031F |
6.2 India AI in Pharmaceutical Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India AI in Pharmaceutical Market Revenues & Volume, By Compound Screening, 2021 - 2031F |
6.2.3 India AI in Pharmaceutical Market Revenues & Volume, By Patient Monitoring, 2021 - 2031F |
6.2.4 India AI in Pharmaceutical Market Revenues & Volume, By Quality Control, 2021 - 2031F |
6.2.5 India AI in Pharmaceutical Market Revenues & Volume, By Consumer Insights, 2021 - 2031F |
6.2.6 India AI in Pharmaceutical Market Revenues & Volume, By Demand Forecasting, 2021 - 2031F |
6.3 India AI in Pharmaceutical Market, By AI Technology |
6.3.1 Overview and Analysis |
6.3.2 India AI in Pharmaceutical Market Revenues & Volume, By Deep Learning, 2021 - 2031F |
6.3.3 India AI in Pharmaceutical Market Revenues & Volume, By AI Predictive Models, 2021 - 2031F |
6.3.4 India AI in Pharmaceutical Market Revenues & Volume, By Robotics & Automation, 2021 - 2031F |
6.3.5 India AI in Pharmaceutical Market Revenues & Volume, By Natural Language Processing, 2021 - 2031F |
6.3.6 India AI in Pharmaceutical Market Revenues & Volume, By AI Algorithms, 2021 - 2031F |
6.4 India AI in Pharmaceutical Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India AI in Pharmaceutical Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4.3 India AI in Pharmaceutical Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.4.4 India AI in Pharmaceutical Market Revenues & Volume, By Pharmaceutical Manufacturers, 2021 - 2031F |
6.4.5 India AI in Pharmaceutical Market Revenues & Volume, By Marketing Agencies, 2021 - 2031F |
6.4.6 India AI in Pharmaceutical Market Revenues & Volume, By Pharmaceutical Distributors, 2021 - 2031F |
7 India AI in Pharmaceutical Market Import-Export Trade Statistics |
7.1 India AI in Pharmaceutical Market Export to Major Countries |
7.2 India AI in Pharmaceutical Market Imports from Major Countries |
8 India AI in Pharmaceutical Market Key Performance Indicators |
8.1 Number of research collaborations between pharmaceutical companies and AI technology providers in India |
8.2 Percentage increase in AI-related patent filings in the pharmaceutical sector |
8.3 Adoption rate of AI-driven tools and technologies in clinical trials and drug development processes in India |
9 India AI in Pharmaceutical Market - Opportunity Assessment |
9.1 India AI in Pharmaceutical Market Opportunity Assessment, By Market Type, 2021 & 2031F |
9.2 India AI in Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 India AI in Pharmaceutical Market Opportunity Assessment, By AI Technology, 2021 & 2031F |
9.4 India AI in Pharmaceutical Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India AI in Pharmaceutical Market - Competitive Landscape |
10.1 India AI in Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 India AI in Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here